3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Glioblastoma
2
Breast Neoplasms
2
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Astrocytoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Rituximab
4
Specimen Handling
3
Biopsy
3
ibrutinib
2
Cladribine
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
obinutuzumab
1
immunotoxin HA22
1
acalabrutinib
1
Vemurafenib
1
Spinal Puncture
1
Prednisone
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
High-Energy Shock Waves
1
Famotidine
1
Doxorubicin
1
Diphenhydramine
1
Dexamethasone
1
Cyclophosphamide
1
Calcium Dobesilate
1
CT-P10
1
Aspirin
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
veliparib
×
30 days
×
Clear all
No trials found.